Blog-Keysee Medtech

The pharmaceutical sector continues to rally, with innovation and international expansion serving as key drivers.

The pharmaceutical sector continues to rally, with innovation and international expansion serving as key drivers.

This week, the pharmaceutical and biotechnology index rose by 1.88%, outperforming the CSI 300 Index by 0.87 percentage points, with year-to-date gains reaching 3.93%. Sub-sectors such as pharmaceutical R&D outsourcing, hospitals, and medical equipment delivered particularly strong performance.

02

2023

/

03

The innovative pharmaceutical market continues to expand, with capital increasingly favoring the Hong Kong Stock Connect healthcare sector.

The innovative pharmaceutical market continues to expand, with capital increasingly favoring the Hong Kong Stock Connect healthcare sector.

According to a report by the Foresight Industry Research Institute, China’s innovative pharmaceutical market has experienced rapid growth, driven by favorable policies, dynamic adjustments to the national medical insurance system, and increased R&D investment.

02

2023

/

03

Expanded authorization for batch release of biological products accelerates product market access.

Expanded authorization for batch release of biological products accelerates product market access.

To enhance the efficiency of batch release for biological products (vaccines), the National Medical Products Administration has decided, on the basis of a thorough risk assessment, to progressively expand the scope of provincial drug regulatory authorities’ testing and inspection institutions authorized to carry out batch release for biological products (vaccines), as well as the range of product types covered.

02

2023

/

03

Multiple Pharmaceutical Companies Collaborate to Advance the Development of Oncology Immunotherapy Drugs

Multiple Pharmaceutical Companies Collaborate to Advance the Development of Oncology Immunotherapy Drugs

Several globally leading pharmaceutical companies have announced a collaboration to jointly advance the research and development of cancer immunotherapy drugs.

02

2023

/

03

Gene-Editing Technologies Empower Rare Disease Drug Development

Gene-Editing Technologies Empower Rare Disease Drug Development

As gene-editing technologies continue to mature, their application in the development of therapies for rare diseases is becoming increasingly widespread.

02

2023

/

03

< 1 2 3 4 5 6 >

Keysee

Polymer tubing

Intervention in consumables OEM

Company Profile
Culture

Neuro Intervention

Peripheral Intervention

Cardiovascular Intervention

Contact Information

IMFORMATION

Contact: Manager Zhang

Tel: +86 15026990525
Email: mkt001@keyseemed.com
Address: No. Y6, Lane 18, Weihang Road, Baoshan District, Shanghai

Contact: Manager Huang
Tel: +86 18795457598
Email: mkt002@keyseemed.com
Address: Building 1, No. 300, Baichuan Road, Haian High-tech Zone

Business license

Jiangsu Keysee Medical Technology Co., Ltd. 丨SEO

Powered by 300.cn